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Abstract
Objectives. To evaluate, by musculoskeletal ultrasound (MSUS), articular involvement in primary SS
(pSS) patients by analysing hand and wrist changes, and to correlate them with clinical evaluation and
laboratory tests.
Methods. Thirty-two pSS patients underwent clinical and laboratory examinations, including the SS
Disease Damage Index (SSDDI) and the SS Disease Activity Index (SSDAI). MSUS was performed in all
patients in both hands and wrists, evaluating the presence of inflammation within joints and periarticular
tissues, and the existence of permanent joint damage. For synovial hypertrophy, joint effusion and Doppler
signal findings, a semi-quantitative score (0–3) was used indicating the degree of involvement (0 = normal;
1 = mild change; 2 = moderate change; and 3 = severe change). For tenosynovitis and bone erosions,
a dichotomous score (0 = absent and 1 = present) was applied.
Results. Sonographic signs of synovitis of the radio-ulno-carpal joint were found in 17 (26.5%) out of 64
wrists. Wrist synovitis was found in 12 (37.5%) out of 32 patients. Ultrasonographic examination of the
hand did not show significant changes. A statistically significant correlation was found between SSDDI
score and the degree of sonographic signs of synovial proliferation in the wrist (P= 0.04). The correlation
between the incidence of clinical involvement and the presence of pathological ultrasonographic findings
was not significant. Patients with synovitis had a higher median age and higher median SSDDI (P= 0.004).
Conclusions. In pSS patients, MSUS may be considered a useful tool for detecting synovitis since
articular involvement can often be silent but correlated with SSDDI.
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Introduction
Primary SS (pSS) is a systemic autoimmune disease
affecting women 9–10 times more commonly than men
and characterized by keratoconjunctivitis sicca, xerosto-
mia, due to chronic focal lymphocytic inflammation,
and other extraglandular abnormalities. Musculoskeletal
manifestations such as fatigue, myalgia, polyarthralgia
and non-erosive symmetric polyarthropathy are the most
common ones and 50% of the patients present with ar-
ticular involvement [1]. Small joint involvement is frequent,
and mild synovitis mimicking RA can be observed [2].
Furthermore, in these patients it is possible to detect
serum RF, and, occasionally, anti-cyclic citrullinated pep-
tide (anti-CCP) antibodies that seem to correlate with the
presence of synovitis [3, 4].
In the last few years, musculoskeletal ultrasound
(MSUS) has been demonstrated to be a useful imaging
technique in the diagnosis and follow-up of various
rheumatic diseases. Thanks to recent improvement in
technology, with the production of more sophisticated
equipment it is actually possible to detect and precisely
define the presence and the entity of inflammation within
joints and periarticular soft tissues, as well as to show the
signs of even minimal structural damage. Using MSUS,
we are able to detect various changes related to
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synovitis, tenosynovitis, bursitis, bone erosions and cartil-
aginous abnormalities. The application of power Doppler
technique provides for an accurate estimate of synovial
perfusion, which increases in the presence of active syno-
vitis [5–9].
We have already shown that, by using MSUS, a slight
knee synovitis (defined as effusion and synovial prolifer-
ation) can be demonstrated in pSS patients [10]. While
in pSS musculoskeletal symptoms are mainly due to
synovitis, in SLE, another CTD, we found a high preva-
lence of tenosynovitis [11].
The aim of the present study was to evaluate hand and
wrist joint changes in patients with pSS and to correlate
them with clinical evaluation and laboratory tests. To our
knowledge our study, executed in pSS, represents the
first attempt to investigate, by using MSUS, a comprehen-
sive involvement of both hand and wrist joints, including
the periarticular structures of those areas.
Patients and methods
This study received ‘Sapienza’ University of Rome ethical
committee approval and all patients gave written informed
consent. Thirty-two consecutive patients with a diagnosis
of pSS, as qualified by the American–European
Consensus Group criteria for SS, were recruited from
the SS outpatient clinic of our rheumatology department.
A rheumatologist (R.P.) asked the detailed clinical history
of all patients and examined joints for clinical signs of
synovitis. Clinical assessment (number of tender and
swollen joints and disease activity score in 28 joints)
was performed in all patients. The SS Disease Damage
Index (SSDDI) and the SS Disease Activity Index (SSDAI)
were also evaluated. ESR, CRP level and anti-SSA anti-
body were evaluated by routine methods according to
in-house protocols. Anti-CCP antibodies were detected
using a commercial anti-CCP2 ELISA kit (Immunoscan
CCP Euro-Diagnostica, Malmo, Sweden). Anti-CCP anti-
bodies were considered positive when the absorbance
value was higher than the cut-off of the kit (25 U/ml). RF
was assayed using the quantitative immunonephelometry
test (Behring, Marburg, Germany). RF was considered
positive when the concentration was higher than the
cut-off value of the kit (15 IU/ml).
Ultrasound examinations
An expert rheumatologist (A.I.), who was blinded to clinical
and laboratory findings, performed MSUS bilaterally in
hand and wrist (radio-ulno-carpal) joints and in the peri-
articular structures of those areas, using a multiplanar
scanning technique, according to published guidelines
[12, 13].
We used a Logiq9 machine (General Electric, Medical
Systems, Milwaukee, WI, USA) equipped with a 9–15 MHz
linear probe. In addition, power Doppler was applied with
the following settings: frequency 7.5; pulse repetition fre-
quency 900 Hz; gain adjusted just below the level that
caused the appearance of noise artefacts; and low filter.
We evaluated the presence of inflammation within joints
and/or periarticular tissues (effusion, synovial proliferation,
hyperaemia in the synovial tissue within the joints and
tendon sheaths) and the existence of permanent joint
damage (bone erosions). Changes within each articular
and periarticular structure were recorded as being present
according to the definitions in the literature [14]. For syn-
ovial hypertrophy, joint effusion and Doppler signal find-
ings, a 4-point semi-quantitative scale (0–3) was used
indicating the degrees of involvement (0 = normal;
1 = mild change; 2 = moderate change; and 3 = severe
change). Mild synovitis was defined in the presence of
minimal synovial proliferation and/or minimal joint effusion
and/or minimal Doppler signal. Moderate synovitis was
defined in the presence of moderate synovial proliferation
and/or minimal–moderate joint effusion and/or minimal–
moderate Doppler signal. Severe synovitis was defined
in the presence of severe synovial hypertrophy and/or
minimal–moderate severe joint effusion and/or minimal–
moderate–severe Doppler signal. For tenosynovitis and
bone erosions, we used a dichotomous score (0 = absent
and 1 = present).
Statistical analysis
The chi-square test with Yates’s correction when required
or Fisher’s exact test when appropriate was used to
evaluate associations of qualitative variables in the differ-
ent groups. Differences between groups were analysed
using the Mann–Whitney U-test. Correlation analysis
was carried out using the Spearman test. A P-value of
0.05 was considered to be statistically significant. SPSS
13 (Chicago, IL, USA) was used for all calculations.
Results
We studied 32 women with pSS: median age 58.5 years
(range 26–69); median disease duration 5 years (range 0–
18). Treatment included, for most of the patients, a low
dose of prednisone equivalent per day and hydroxychlor-
oquine (400 mg/day). Clinical evaluation revealed the
presence of 13 (20.3%) tender wrists and 3 (4.6%) swollen
wrists. Hand clinical examination showed that 101 MCP
(31.5%) and 78 PIP (24.3%) joints of 33 hands were
tender, and 33 MCP (10.3%) and 54 PIP (16.8%) joints
of 22 hands were swollen. The mean number of hand
tender joints was 2.55 (S.D. = 3.6) and the mean number
of hand swollen joints was 1.24 (S.D. = 2.3).
Serological activity parameters showed median ESR as
26 mm/h (range 7–96); 22 (68.7%) patients were positive
for RF, 25 (78.1%) for anti-SSA and 1 (3.1%) for anti-CCP
antibodies. The median number of painful joints was 5.5
(range 0–28) and swollen joints was 1 (range 0–22). The
median SSDAI score was 1 (range 0–4) and the median
SSDDI score was 1 (range 0–5).
Ultrasonographic findings of this study are reported
in Tables 1 and 2. Sonographic signs of synovitis of the
radio-ulno-carpal joint (Fig. 1) were found in 17 (26.5%) of
the 64 studied wrists. Totally, wrist synovitis was found in
12 (37.5%) out of 32 patients. In 10 wrists we could detect
a moderate synovitis (58.8%), in 7 wrists mild synovitis
(41.1%) and in none of the patients did we observe
severe synovitis. In particular, synovial proliferation was
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present in 19 (29.6%) joints, PD positivity in 16 (25%) and
joint effusion in 28 (43.7%). Erosions were found in two
wrists of one patient. Signs of tenosynovitis of one or
more tendons at the wrist level were never present. In
27 (42.1%) wrists no alterations were found.
Ultrasonographic examination of the hand showed few
and poor significant pathological changes. In fact, sono-
graphic signs of hand synovitis were detected in only 3
(0.3%) hand joints (always 2 PIP) out of 896 examined.
The grade of synovitis was mild in two cases and moder-
ate in one case. In total, we observed hand synovitis in
only 2 (6.2%) out of 32 patients. In particular, synovial
proliferation was present in 30 (3.3%) joints, PD positivity
in 3 (0.3%) and joint effusion in 5 (0.5%). Signs of teno-
synovitis at the hand level were present only at the flexor
tendons of the third finger. Erosions were never
found. In 863 (96.3%) hand joints no alterations were
detected.
A statistically significant correlation was demonstrated
between the SSDDI score and the degree of sonographic
signs of synovial proliferation in the wrist (P= 0.04).
The SSDAI score was significantly related to the number
of tender joints and the titre of RF (P= 0.02). Moreover, we
observed a positive correlation between the number of
tender joints and joint effusion showed by ultrasound
(US) (P= 0.01). No statistically significant correlations
were found between tender and swollen joints detected
by physical examination, and the presence and the
degree of synovitis revealed by using MSUS.
Interestingly, the clinical signs of synovitis in the wrist
were less frequent than synovitis detected by MSUS.
Moreover, considering the higher percentage of syno-
vitis at the wrist level, we divided our patients into two
different subgroups, based on the presence/absence of
radio-ulno-carpal joint synovitis. We could detect that
patients with wrist synovitis had a median age of 64
years (range 43–68), whereas patients without synovitis
had a median age of 48.5 years (range 26–69;
P= 0.005). All patients with wrist synovitis were RF and
anti-SSA positive. A statistically significant correlation
was found between synovitis and RF positivity (P= 0.01).
Furthermore, patients presenting with synovitis had a
median SSDDI of 2 (range 0–3), whereas patients without
synovitis had a median SSDDI of 1 (range 0–5; P= 0.004).
Clinical and demographic characteristics of patients with
subclinical synovitis and with symptomatic synovitis were
not different.
Table 1 Ultrasonographic findings in hand and wrist joints
US findings
Synovial
proliferation
Power
Doppler
Joint
effusion Erosion
Tendon
sheath
distension
1 MCP 2 0 0 0 0
2 MCP 2 0 1 0 0
3 MCP 1 0 1 0 1
4 MCP 2 0 0 0 0
5 MCP 2 0 0 0 0
1 IP 2 0 0 0 0
2 PIP 5 3 2 0 0
3 PIP 2 0 0 0 0
4 PIP 2 0 0 0 0
5 PIP 2 0 0 0 0
2 DIP 2 0 1 0 0
3 DIP 2 0 0 0 0
4 DIP 2 0 0 0 0
5 DIP 2 0 0 0 0
Total 30 3 5 0 1
Wrist 19 16 28 2 0
PIP: proximal interphalangeal; DIP: distal interphalangeal.
Table 2 Grade of ultrasonographic synovitis in hand and
wrist joints
US degree of synovitis Mild Moderate Severe
1 MCP 0 0 0
2 MCP 0 0 0
3 MCP 0 0 0
4 MCP 0 0 0
5 MCP 0 0 0
1 IP 0 0 0
2 PIP 2 1 0
3 PIP 0 0 0
4 PIP 0 0 0
5 PIP 0 0 0
2 DIP 0 0 0
3 DIP 0 0 0
4 DIP 0 0 0
5 DIP 0 0 0
No. of hand synovitis 2 1 0
No. of wrist synovitis 7 10 0
PIP: proximal interphalangeal; DIP: distal interphalangeal.
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Discussion
pSS is a systemic autoimmune disease affecting mainly
the function of salivary and lacrimal glands. The clinical
spectrum of the disease is wide and extraglandular symp-
toms are very common. Articular involvement is reported,
by several studies, as a frequent manifestation in these
patients who mostly complain of arthralgias rather than
arthritis [15–19]. In a large cohort of 1010 Spanish pa-
tients, the authors found that the main extraglandular
manifestation was arthralgia (48%), whereas arthritis
was present only in 15% of patients [20]. In a prospective
study, Haga and Peen [21] analysed the pattern of arth-
ritis, evaluated by clinical examination, in pSS patients. In
this study, arthralgia was found in 73.5% of patients and
arthritis in 17.6%, it was mild, resolving and not correlated
with immunological and clinical aspects. The authors
encouraged an ultrasonography study of hand joints in
patients with pSS, so in this light we consider our study
to be on time. While we showed a low prevalence of
anti-CCP antibodies in pSS patients, the percentage of
a moderate–mild degree of synovitis, detected by
MSUS, was higher (26.5% vs 17.6%) than that reported
by Haga and Peen. Our results confirm that MSUS is a
more sensitive method to reveal joint involvement com-
pared with simple clinical evaluation, and, most import-
antly, it also allows disclosure of subclinical disease. In
fact, we did not find any significant correlation between
joint clinical involvement, and the presence and the
degree of synovitis revealed by MSUS. Thus, MSUS can
help to show silent synovitis and this concept was already
demonstrated in early, untreated oligoarthritis patients,
where MSUS detected a high prevalence of subclinical
synovitis. In fact, on the basis of these results, the authors
wondered if oligoarthritis should be reclassified consider-
ing that having only clinical examination could be im-
proper [22]. Many previous studies have shown that
MSUS is a sensitive imaging technique able to reveal
early synovial pathological changes and has demon-
strated its superiority over clinical examination [9, 23].
In analogy to a Swedish study which demonstrated that
subclinical myositis did not correlate with muscle pain in
pSS patients [24], we have shown, by using MSUS, sub-
clinical synovitis in patients without any symptoms.
Moreover, we found a correlation between the degree of
sonographic signs of synovial proliferation and the SSDDI
score. In this light, MSUS could be considered a useful
tool in the follow-up of these patients who can show a
wide spectrum of symptomatic and subclinical
manifestations.
We did not find any correlation between the presence
and the degree of synovitis and disease duration, but
dividing our patients into two different subgroups
based on the presence/absence of wrist synovitis, we
found that all patients with synovitis were RF and
anti-SSA positive, and had a higher median age and
higher SSDDI, suggesting that the presence of wrist syno-
vitis might be considered as a sign of more severe dis-
ease. These findings have also been confirmed by
positivity of serological parameters. Since clinical and
demographic characteristics of patients with subclinical
synovitis and symptomatic synovitis were not different,
we suggest further study of these patients by using
MSUS to eventually disclose a subset of subjects with a
disease that requires more aggressive treatment and tight
monitoring.
In conclusion, our study confirms that MSUS may be
considered a useful tool for detecting synovitis in pSS
patients, since this aspect can often be clinically silent
and correlated with SSDDI. Furthermore, even though
we observed a mild and self-limiting arthritis in most of
the patients, the positivity of power Doppler signal could
indicate more aggressive and active disease that might
eventually lead to the appearance of erosive joint damage.
As far as we know, our study for the first time showed,
by using MSUS, prevalent wrist joint involvement with
signs of mild–moderate synovitis even in asymptomatic
patient. Our findings thus confirm once again the useful-
ness of MSUS in detecting joint changes, in particular,
demonstrating subclinical disease. Sonography can be
FIG. 1 Longitudinal dorsal scan of the wrist showing mild synovitis of the wrist joint.
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used to assess the pathological process and the presence
of active joint inflammation, offering useful data in order to
adopt the most adequate therapy in pSS patients.
Rheumatology key messages
. Sonography detects subclinical synovitis in pSS.
. MSUS is a useful imaging tool for analysing hand
and wrist joint changes in pSS.
Disclosure statement: The authors have declared no con-
flicts of interest.
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